Jefferies Remains a Buy on Cigna (CI)
Jefferies analyst David Windley maintained a Buy rating on Cigna today and set a price target of $330.00.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Windley is a 5-star analyst with an average return of 8.1% and a 57.98% success rate. Windley covers the Healthcare sector, focusing on stocks such as Humana, UnitedHealth, and Centene.
In a report released on April 13, Bank of America Securities also maintained a Buy rating on the stock with a $378.00 price target.
Based on Cigna’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $72.47 billion and a net profit of $1.23 billion. In comparison, last year the company earned a revenue of $65.65 billion and had a net profit of $1.42 billion
Read More on CI:
Disclaimer & DisclosureReport an Issue
- AxoGen jumps after Cigna picks up Avance nerve graft
- 3 “Strong Buy” Blue Chip Stocks to Buy in April 2026, According to Analysts
- One in seven enrollees in ACA plans failed to make payments this year, WSJ says
- Midday Fly By: Health insurers get ‘positive surprise’ from CMS
- CMS finalizes 2027 Medicare Advantage payments with 2.48% increase
